New Jersey · 2026-2027 Regular Session · Bill

A 1816: Requires hospitals to test for fentanyl and xylazine as part of urine drug screenings.

In committee Last action January 13, 2026: Introduced, Referred to Assembly Health Committee

Plain-language summary

A 1816 is a bill introduced in the New Jersey House on January 13, 2026. According to its official title, it concerns: Requires hospitals to test for fentanyl and xylazine as part of urine drug screenings. Primary sponsor: Anthony Verrelli (Democratic), Dawn Fantasia (Republican). It lists 2 additional sponsors. Most recent recorded action (January 13, 2026): Introduced, Referred to Assembly Health Committee.

Sponsors

Primary sponsors: Anthony Verrelli (Democratic); Dawn Fantasia (Republican). 2 co-sponsors.